| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 204.79M | 241.62M | 253.45M | 348.93M | 561.70M |
| Gross Profit | 43.43M | 58.03M | 60.73M | 64.20M | 76.91M |
| EBITDA | -14.87M | -30.22M | 12.95M | -55.63M | 3.80M |
| Net Income | -63.15M | -48.57M | 1.75M | -72.35M | -12.41M |
Balance Sheet | |||||
| Total Assets | 706.43M | 773.67M | 843.16M | 743.98M | 864.02M |
| Cash, Cash Equivalents and Short-Term Investments | 95.84M | 49.77M | 73.61M | 69.04M | 79.20M |
| Total Debt | 80.69M | 65.87M | 43.38M | 53.23M | 54.92M |
| Total Liabilities | 308.04M | 301.64M | 315.34M | 250.74M | 293.45M |
| Stockholders Equity | 309.33M | 372.34M | 421.13M | 419.38M | 491.42M |
Cash Flow | |||||
| Free Cash Flow | 25.80M | -50.25M | 578.00K | 19.81M | -24.70M |
| Operating Cash Flow | 72.27M | 7.21M | 34.18M | 36.50M | 22.57M |
| Investing Cash Flow | -36.89M | -53.98M | -18.13M | -21.09M | -34.07M |
| Financing Cash Flow | 10.64M | 22.93M | -11.48M | -15.54M | -6.68M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$9.31B | 9.98 | 8.67% | 4.37% | 0.90% | 11.31% | |
71 Outperform | HK$12.10B | 17.66 | 7.72% | 6.19% | 7.14% | 3.17% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | HK$682.66M | 2.54 | 5.77% | ― | -14.62% | -19.99% | |
50 Neutral | HK$1.23B | 3.90 | 3.96% | ― | 1.03% | 16.29% | |
45 Neutral | HK$293.33M | -4.02 | -12.96% | ― | -15.06% | -30.89% | |
44 Neutral | HK$3.89B | -3.18 | -30.08% | ― | 0.62% | -58.08% |